Skip to main navigation Skip to search Skip to main content

Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology

  • University of Vermont

Research output: Contribution to journalReview articlepeer-review

167 Scopus citations

Abstract

Myasthenia gravis (MG) is a rare disease, but the most common disorder of the neuromuscular junction. It is the prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine receptor (AChR) leading to characteristic fatigable weakness of the ocular, bulbar, respiratory, axial, and limb muscles. The majority of patients with MG first present with ocular symptoms. Most patients with MG will experience at least 1 exacerbation of symptoms throughout the course of their illness. This article will cover the epidemiology, clinical presentation, classification, and natural history of MG.

Original languageEnglish
Pages (from-to)253-260
Number of pages8
JournalNeurologic Clinics
Volume36
Issue number2
DOIs
StatePublished - May 2018

Keywords

  • Acetylcholine receptor
  • Antimuscle-specific kinase
  • Myasthenia gravis
  • Occular

Fingerprint

Dive into the research topics of 'Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology'. Together they form a unique fingerprint.

Cite this